MDMA elicits behavioral and neurochemical sensitization in rats

Neuropsychopharmacology

Volumn 18, Issue 6, 1998, Pages 469-479

  Kalivas, Peter W ^a,b   Duffy, Patricia ^a,b   White, Susan R ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Pharmacology   (United States)

Author keywords

Cocaine; Locomotion; MDMA; Microdialysis; Nucleus accumbens; Sensitization

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ARTICLE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SENSITIZATION;

ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; ELECTROCHEMISTRY; HALLUCINOGENS; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0031944699     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00195-4     Document Type: Article

References (61)

1. Akimoto K, Hamamura T, Kazahaya Y, Akiyama K, Otsuki S Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine - An in vivo dialysis study in freely moving rats. Brain Res. 507:1990;344-346.
2. Antelman SM Stressor-induced sensitization to subsequent stress. Implications for the development and treatment of clinical disorders Kalivas PW, Barnes CD Sensitization in the Nervous System. 1988;227-256 Telford Press, Caldwell, NJ.
3. Beardsley PM, Balster RL, Harris LS Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend. 18:1986;149-157.
4. Benzazzi F, Mazzoli M Psychiatric illness associated with "ecstasy." Lancet. 388:1991;1520.
5. Bilsky EJ, Hui Y, Hubbell CL, Reid LD Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage. Pharmacol Biochem Behav. 37:1990;633-638.
6. Brady KT, Lydiard RB, Malcolm R, Ballenger JC Cocaine-induced psychosis. J Clin Psychiatry. 52:1991;509-512.
7. Callaway CW, Geyer MA Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat. Eur J Pharmacol. 214:1992;45-51.
8. Callaway CW, Wing LL, Geyer MA Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther. 254:1990;456-464.
9. Callaway CW, Johnson MP, Gold LH, Nichols DE, Geyer MA Amphetamines derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. Psychopharmacology. 104:1991;293-301.
10. 1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine. Neuropsychopharmacology. 5:1992;113-127.
11. Creighton FJ, Black DL, Hyde CE Ecstasy psychosis and flashbacks. Br J Psychol. 159:1991;713-715.
12. Cunningham KA, Paris JM, Goeders NE Serotonin neurotransmission in cocaine sensitization. Ann NY Acad Sci. 654:1992;117-127.
13. Dafters RI Hyperthermia following MDMA administration in rats. Effects of ambient temperature, water consumption, and chronic dosing Physiol Behav. 5:1995;877-882.
14. Deutch AY, Tam S-Y, Roth RH Footshock and conditioned stress increase in 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res. 333:1985;143-146.
15. Ellinwood EH Amphetamine psychosis. I. Description of the individuals and process. J Nerv Ment Dis. 144:1967;273-283.
16. Fitzgerald JL, Reid JJ Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices. Eur J Pharmacol. 191:1990;217-220.
17. Gartside SE, McQuade R, Sharp T Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo. J Pharmacol Exp Ther. 279:1996;277-283.
18. Geyer MA Serotonergic functions in arousal and motor activity. Behav Brain Res. 73:1996;31-35.
19. Gold LH, Koob GF MDMA produces stimulant-like conditioned locomotor activity. Psychopharmacology. 99:1989;352-356.
20. Gough B, Ali SF, Slikker W Jr., Holson RR Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav. 39:1991;619-623.
21. Green AR, Cross AJ, Goodwin GM Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology. 119:1995;247-260.
22. Gudelsky GA, Nash JF Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine. Im-plications for serotonin-dopamine interactions J Neurochem. 66:1996;243-249.
23. Heidbreder CA, Thompson AC, Shippenberg TS Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther. 278:1996;490-502.
24. 1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther. 258:1991;882-890.
25. Johnson MP, Hoffman AJ, Nichols DE Effects of enantiomers of MDA, MDMA and related analogues on 3H-serotonin and 3H-dopamine release from superfused rat brain slices. Eur J Pharmacol. 132:1986;269-276.
26. Kalivas PW, Duffy P Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci. 13:1993;266-275.
27. Kalivas PW, Stewart J Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev. 16:1991;223-244.
28. Kalivas PW, Duffy P, DuMars LA, Skinner C Neurochemical and behavioral effects of acute and daily cocaine. J Pharmacol Exp Ther. 245:1988;485-492.
29. Kolta MG, Shreve P, De Souza V, Uretsky NJ Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology. 24:1985;823-829.
30. Lamb RJ, Griffiths RR Self-injection of 3,4-methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology. 91:1987;268-272.
31. Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE Reinforcing effects of certain serotonin-releasing amphetamine derivatives. Pharmacol Biochem Behav. 53:1996;99-105.
32. McCann UD, Ricaurte GA Lasting neuropsychiatric sequelae of (+)-3,4-methylenedioxymethamphetamine ("ecstasy") in recreational users. J Clin Psychopharmacol. 11:1991;302-305.
33. McNamara MG, Kelly JP, Leonard BE Some behavioural and neurochemical aspects of subacute (±)3,4-methylenedioxymethamphetamine administration in rats. Pharmacol Biochem Behav. 52:1995;479-484.
34. Milliken GA, Johnson DE Analysis of Messy Data. Vol. I. Designed Experiments:1984;Lifetime Learning Publications, Belmont, CA.
35. Nash JF, Brodkin J Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release. Effect of dopamine uptake inhibitors J Pharmacol Exp Ther. 259:1991;820-825.
36. O'Hearn E, Battaglia G, DeSouza EB, Kuhar MJ, Molliver ME Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain. Immunocytochemical evidence for neurotoxicity J Neurosci. 8:1988;2788-2803.
37. Paulson PE, Robinson TE Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum. A microdialysis study in behaving rats Synapse. 19:1995;56-65.
38. Paulson PE, Camp DM, Robinson TE Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology. 103:1991;480-492.
39. Paxinos G, Watson C The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
40. Pelligrino LK, Pellegrino AS, Cushman AJ A Stereotaxic Atlas of the Rat Brain. 1979;Plenum Press, New York.
41. Pettit HO, Pan H-T, Parsons LH, Justice JB Jr. Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem. 55:1990;798-804.
42. Post RM Cocaine psychosis. A continuum model J Psychiatry. 132:1975;225-231.
43. Robinson TE, Becker JB Enduring changes in brain and behavior produced by chronic amphetamine administration. A review and evaluation of animal models of amphetamine psychosis Brain Res Rev. 11:1986;157-198.
44. Robinson TE, Wishaw IQ Normalization of extracellular dopamine in the striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra. A microdialysis study in freely moving rats Brain Res. 450:1988;209-224.
45. Robinson TE, Jurson PA, Bennett JA, Bentgen KM Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine. A microdialysis study in freely moving rats Brain Res. 462:1988;211-222.
46. Satel SL, Southwick SM, Gawin FH Clinical features of cocaine-induced paranoia. Am J Psychiatry. 148:1991;495-498.
47. 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine. J Neurochem. 62:1994;1382-1389.
48. Segal DS, Kuczenski R Individual differences in responsiveness to single and repeated amphetamine administration. Behavioral characteristics and neurochemical correlates J Pharmacol Exp Ther. 242:1987;917-926.
49. Segal DS, Schuckit MA Animal models of stimulant-induced psychosis. Creese I Stimulants. Neurochemical, Behavioral, and Clinical Perspectives:1983;131-167 Raven Press, New York.
50. Seiden LS, Sabol KE, Ricuarte GA Amphetamine. Effects on catecholamine systems and behavior Annu Rev Pharmacol Toxicol. 33:1993;639-677.
51. Series HG, Cowen PJ, Sharp T p-Chloroamphetamine (PCA), 3,4-methylenedioxymethamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology. 116:1994;508-514.
52. Spanos LJ, Yamamoto BK Acute and subchronic effects of methylenedioxymethamphetamine [(±)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav. 32:1989;835-840.
53. Steele TD, McCann UD, Ricaurte GA 3,4-methylenedioxymethamphetamine (MDMA, "Ecstacy"). Pharmacology and toxicology in animals and humans Addiction. 89:1994;539-551.
54. Stewart J, Vezina P Conditioning and behavioral sensitization. Kalivas PW, Barnes CD Sensitization in the Nervous System. 1988;207-224 Telford Press, Caldwell, NJ.
55. Whitaker-Azmitia PM, Aronson TA "Ecstacy" (MDMA)-induced panic. Am J Psychiatry. 146:1989;119.
56. White SR, Duffy P, Kalivas PW Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo. Neuroscience. 62:1994;41-50.
57. White SR, Obradovic T, Imel KM, Wheaton MJ The effects of methylenedioxymethamphetamine (MDMA, "ecstacy") on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol. 49:1996;455-479.
58. Wilson MA, Ricaurte GA, Molliver ME Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug, 3,4-methylenedioxymethamphetamine. Neuroscience. 28:1989;121-137.
59. Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther. 264:1993;249-255.
60. Yamamoto BK, Spanos LJ The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol. 148:1988;195-203.
61. Yamamoto BK, Nash JF, Gudelsky GA Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and g-aminobutyric acid in the substantia nigra. J Pharmacol Exp Ther. 273:1995;1063-1070.